L. Becker Hewes, Chief Medical Officer at Blueprint Medicines Corp (BPMC), sold 2,584 shares at $89.03 ($230K) on 2021-06-02, disclosed to the SEC on 2021-09-17.
Open-market sale of $230k BPMC by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $89.03 | 1,292 | $115K | 50.0% |
| 2 | $89.03 | 1,292 | $115K | 50.0% |
| Total | $89.03 avg | 2,584 | $230K | 100% |
| Filing → |
| BPMC | SELL | 2024-06-04 | $8.3M | — | Filing → |
| BPMC | SELL | 2024-03-11 | $562K | — | Filing → |
| BPMC | SELL | 2023-06-07 | $146K | — | Filing → |